Validation of a rapid one-step high sensitivity real-time quantitative PCR system for detecting major BCR-ABL1 mRNA on an International Scale

Por Yoshida, Chikashi, Nakamae, Hirohisa, Fletcher, Linda, Koga, Daisuke, Sogabe, Takayuki, Matsumura, Itaru, Kanakura, Yuzuru, Branford, Susan, Naoe, Tomoki
Publicado no Springerplus (2016)

Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transc...

Por Shiseki, Masayuki, Yoshida, Chikashi, Takezako, Naoki, Ohwada, Akira, Kumagai, Takashi, Nishiwaki, Kaichi, Horikoshi, Akira, Fukuda, Tetsuya, Takano, Hina, Kouzai, Yasuji, Tanaka, Junji, Morita, Satoshi, Sakamoto, Junichi, Sakamaki, Hisashi, Inokuchi, Koiti
Publicado no Int J Clin Oncol (2017)

Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation

Por Kumagai, Takashi, Nakaseko, Chiaki, Nishiwaki, Kaichi, Yoshida, Chikashi, Ohashi, Kazuteru, Takezako, Naoki, Takano, Hina, Kouzai, Yasuji, Murase, Tadashi, Matsue, Kosei, Morita, Satoshi, Sakamoto, Junichi, Wakita, Hisashi, Sakamaki, Hisashi, Inokuchi, Koiti
Publicado no Cancer Sci (2017)

Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of mole...

Por Takahashi, Naoto, Miura, Masatomo, Kuroki, Jun, Mitani, Kinuko, Kitabayashi, Atsushi, Sasaki, Osamu, Kimura, Hideo, Imai, Kiyotoshi, Tsukamoto, Norifumi, Noji, Hideyoshi, Kondo, Takeshi, Motegi, Mutsuhito, Kato, Yuichi, Mita, Masayuki, Saito, Hajime, Yoshida, Chikashi, Torimoto, Yoshihiro, Kimura, Tomofumi, Wano, Yuji, Nomura, Jun, Yamamoto, Satoshi, Mayama, Ko, Honma, Riko, Sugawara, Tomohiro, Sato, Shinji, Shinagawa, Atsushi, Abumiya, Maiko, Niioka, Takenori, Harigae, Hideo, Sawada, Kenichi
Publicado em 2014